July 6, 2020

The Niche

Knoepfler lab stem cell blog

Uncategorized

3 min read

When you write a book like our new dragon book, as the first reviews of it start coming in you just never know what they’ll be like. When the person or outlet doing the review has a huge audience, the stakes are higher. How have the early reviews been for our new How to Build a Dragon or Die Trying book? For background, my daughter Julie and I wrote a book about how one would try to make a real, living, fire-breathing dragon. You …Read More

2 min read

Stem cell treatment cost is a big issue for patients now and longer term also for the stem cell field. If proven stem cell treatments end up costing too much then all that hard work to invent and test the therapies won’t have helped people much. Million or multi-million dollar new therapies are not so unusual these days in the biotech world. Here are some recent examples: From ASH Clinical News on a Novartis drug:“AVXS-101, a treatment for spinal muscular atrophy, will cost $4 …Read More

3 min read

When you read “spam, spam, spam” do you think of Monty Python? I do. Some folks may immediately think of email spam. There might even be a connection between the ubiquitous email spam and the old Monty Python spam. See the video below. What’s spam got to do with stem cells? Is there stem cell or cellular spam? Hold on a sec. When I first started The Niche blog almost a decade ago in early 2010, so much was different. This blog wasn’t even …Read More

2 min read

In a surprise, Dr. Masayo Takahashi has announced that she has left RIKEN. Takahashi indicates she will be new President of a company called Vision Care, Inc. as part of the Kobe Eye Center. I’ve pasted a picture of Takahashi’s Tweet with translation more toward the bottom of the post. A big thanks to Piero Carninci, a biologist at RIKEN, for the heads up on this news. I’m sure they are very sad to see her go, but wish her the best! Here is …Read More